MENU
BBOT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BridgeBio Oncology Therapeutics (BBOT) Earnings Date & Reports
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more
A.I. Advisor
published Earnings
BBOT is expected to report earnings to fall 1.16% to -51 cents per share on September 02
Q2'26
Est.
$-0.52
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
The last earnings report on May 12 showed earnings per share of -52 cents, missing the estimate of -46 cents. With 209.69K shares outstanding, the current market capitalization sits at 630.44M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information